SLU Institute for Drug & Biotherapeutic Innovation

The Saint Louis University Institute for Drug and Biotherapeutic Innovation (SLU-IDBI) is a multidisciplinary association of researchers with a shared interest in drug and biotherapeutic discovery and development.  SLU-IDBI members have skills and expertise that range the full spectrum of what is needed for drug discovery and development, including target identification and validation, primary drug screening, medicinal chemistry optimization of screening hits, pharmacological characterization and optimization of promising compounds, and clinical trials for novel therapeutics. We provide drug discovery educational and networking opportunities and are interested in partnering with like-minded researchers in academia and industry.